Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kelda G. Schonhoff"'
Autor:
Michelle Y. Zhang, Megan Othus, Carole Shaw, Kelda G. Schonhoff, Anna B. Halpern, Jacob Appelbaum, Paul C. Hendrie, Roland B. Walter, Elihu H. Estey, Mary-Elizabeth M. Percival
Publikováno v:
Leukemia & Lymphoma. :1-7
Autor:
Carla S. Walti, Anna B. Halpern, Hu Xie, Erika S. Kiem, E. Lisa Chung, Kelda G. Schonhoff, Emily M. Huebner, Colleen Delaney, Catherine Liu, Steven A. Pergam, Guang-Shing Cheng, Louise E. Kimball, Wendy M. Leisenring, Michael Boeckh, Roland B. Walter, Joshua A. Hill
Publikováno v:
Leukemia. 37:298-307
Autor:
Julian Lindsay, Carla S. Walti, Anna B Halpern, Hu Xie, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Guang-Shing Cheng, Louise Kimball, Wendy M Leisenring, Matthew Greenwood, Sharon C-A Chen, David CM Kong, Monica A. Slavin, Michael Boeckh, David Fredricks, Catherine Liu, Steven A. Pergam, Roland B Walter, Joshua A. Hill
Publikováno v:
Blood Advances.
CLAG-M (cladribine, high-dose cytarabine [HiDAC], G-CSF, mitoxantrone)/CLAG are contemporary intensive chemotherapy regimens associated with higher and deeper complete remission rates than 7+3 (cytarabine, anthracycline)/HiDAC, but with greater myelo
Autor:
Carla S, Walti, Anna B, Halpern, Hu, Xie, Erika S, Kiem, E Lisa, Chung, Kelda G, Schonhoff, Emily M, Huebner, Colleen, Delaney, Catherine, Liu, Steven A, Pergam, Guang-Shing, Cheng, Louise E, Kimball, Wendy M, Leisenring, Michael, Boeckh, Roland B, Walter, Joshua A, Hill
Publikováno v:
Leukemia.
Contemporary data on infections after intensive chemotherapy for acute myeloid leukemia (AML) are scarce. Cladribine, high-dose cytarabine, G-CSF, and dose-escalated mitoxantrone ("CLAG-M") may result in higher remission rates than standard-dose cyta